Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure

Journal of Infection

Volumn 47, Issue 1, 2003, Pages 77-81

  Dereure, J ^a   Duong Thanh, H ^b   Lavabre Bertrand, T ^a   Cartron, G ^b   Bastides, F ^b   Richard Lenoble, D ^b   Dedet, J P ^a  

^a UNIV MONTPELLIER   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Leishmania; Lymph node; Lymphoma; Pregnancy; Survival; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; CYCLOPHOSPHAMIDE; DOXORUBICIN; MEGLUMINE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; BLOOD CULTURE; BONE MARROW CULTURE; BONE MARROW EXAMINATION; CASE REPORT; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOFLUORESCENCE TEST; LEISHMANIA; LYMPHADENOPATHY; MALE; PARASITE ISOLATION; PATHOLOGY; POLYMERASE CHAIN REACTION; VISCERAL LEISHMANIASIS;

EID: 0038495613     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(03)00002-1     Document Type: Article

References (28)

1. Hernandez-Pérez J, Yebra-Bango M, Jiménez-Martinez E, et al. Visceral leishmaniasis (Kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 1999;29:918-921.
2. Sellami H, Ayadi A, Makni F. La leishmaniose viscérale de l'adulte au cours d'une immunodépression non liée au SIDA. Bull Soc Fr Parasitol 1998;16:80-85.
3. Quilici M, Dunan S, Dumon H, Franck J, Gambarelli F, Toga I. La leishmaniose viscérale humaine en Provence. Méd Chir Digest 1987;16:511-514.
4. Bada JL, Arderiu A, Gimenez J, Gomez-Acha JA. Kala-azar of long standing evolution in an asplenic patient. Trans R Soc Trop Med Hyg 1979;73:347-348.
5. Benhamou E, Ferrand B, Chiche JC, Sudaka C. Maladie de Hodgkin et Kala-Azar, Remarques cliniques, biologiques, thérapeutiques et anatomo-pathologiques. Press Méd 1955; 86:1778-1781.
6. Magnan A, Jacqueme P, Sudan N, Redding E, Blanc AP, Poirier R. Leishmaniose viscérale associée à une maladie de Hodgkin: difficultés diagnostiques. Rev Pneumol Clin 1991; 47:188-191.
7. Moukassa D, Jermidi C, Copin MC, Leroy X, Devisme L, Gosselin B. Hepatic large cell non-Hodgkin's lymphoma associated with visceral leishmaniasis in an AIDS patient. Gastroenterol Clin Biol 1999;23:415-416.
8. Hauteville D, Chagnon A, Camilleri G, Herne N, Verdier M. Leishmaniose viscérale méditerranéenne chez un leucémique en rémission. Nouv Press Méd 1980;9:1713-1714.
9. Di Cataldo A, Lo Nigro L, Marino S, Schiliro G. Visceral leishmaniasis in three children with leukemia. Pediat Infect Dis J 1996;15:916-918.
10. Mulliez P, Dabouz R, Demory JL, Darras A, Crinquette J. Une observation de leishmaniose chez un malade traité par corticoïdes pour sarcoïdose. Méd Mal Infect 1987;6: 412-413.
11. Wallis PJW, Clarck CJM. Visceral leishmaniasis complicating systemic lupus erythematosus. Ann Rheum Dis 1983;42: 201-202.
12. Gastelbled G, Nurit Y, Bencler A, Lafaix C. Kala-azar et grossesse. J Gyn Obstet Biol Reprod 1973;2:1067-1071.
13. Utili R, Rambaldi A, Tripodi MF, Andreana A. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate. Infection 1995;23:182-183.
14. Loke YW, King A. Immunological aspects of human implantation. J Reprod Fertil 2000;55:83-90.
15. Badaro R, Carvalho EM, Rocha H, Queiroz AC, Jones TC. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocomprimised patients. Lancet 1986;1:647-648.
16. Matzdorff AC, Matthes K, Kemkes-Matthes B, Pralle H. Viszeral Leishmaniose mit ungewohnlich langer Inkubationszeit. Dt med Wschr 1997;122:890-894.
17. Krishnan L, Guilbert LJ, Wegmann TG, Betosevic M, Mosmann TR. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J Immunol 1996;156:653-662.
18. Krishnan L, Guilbert LJ, Russet A, Wegmann TG, Mosmann TR, Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol 1996;156:644-652.
19. Low GC, Cook WE. A congenital case of Kala-azar. Lancet 1926;211:1209-1211.
20. Sharma R, Bahl L, Goel A, Upadhaya A, Kaushik SL. Congenital kala azar. A case report. J Commun Dis 1996; 28:59-61.
21. Meinecke CK, Schottelius J, Oskam L, Fleisher B. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Pediatrics 1999;104:65.
22. Peachey AM, Irvine GH, White H. Visceral leishmaniasis. an unusual cervical presentation. Brit J Oral Maxillofacial Surg 1994;32:325-327.
23. Ardehali S, Sadeghi-Hassanabadi A, Moaddeb A, Abdollahi B, Malek-Hosseini Z, Avans DA. The characterization of Leishmania from patients with lymphadenopathy in Shiraz, Iran. Trans R Soc Trop Med Hyg 1995;89:370-371.
24. Aragort De Rossell R, De Jesus De Duran R, Rossell O, Rodriguez AM. Is leishmaniasis ever cured ? Trans R Soc Trop Med Hyg 1992;86:251-253.
25. Bogdan C, Donhauser N, Doring R. Rollinghoff M, Diefenbach A, Rittig MG. Fibroblasts as hosts cells in latent leishmaniosis. J Exp Med 2000;191:2121-2130.
26. Nuwayri-Salti N, Muatassem D, Salman S, Izzedine N, Ghani Kibbi A. Chronic cutaneous leishmaniasis: Leishmania parasites in blood. Intern J Dermatol 1992;31:562-564.
27. Guillaud V, Hill MP, Piens MA, Barrut D, Moulin G. Leishmaniose cutanée évoluant depuis 48 ans. Ann Dermatol Vénéréol 1991;118:850-851.
28. Antoine JC, Lang T, Prina E. Biologie cellulaire de Leishmania. In: Dedet JP, editor. Les Leishmanioses; Paris: Ellipses Publisher. 1992. p. 41-58.